Resources

Aiming to Create Innovative Pharmaceuticals by Combining AI-Driven Drug Discovery with Research on Unfolded Protein Response, a Field Associated with Potential Candidates for the Nobel Prize in Physiology or Medicine

Developing and Evaluating a New Model Using the Equation-Driven AI "KIBIT" for the Early Detection of Alzheimer's Disease, Which Begins Approximately 20 Years Before Onset— Demonstrated Through a Cohort Study of Approximately 800 Beppu Residents —

 Driving Pipeline Expansion in the Ophthalmology Field Using the AI-powered Drug Discovery Support Service "Drug Discovery AI Factory" 

Results presented at the 53rd Annual Meeting of the Japanese Society of Toxicology, utilizing the AI-driven drug discovery support service "Drug Discovery AI Factory"

Launches “KIBIT Amanogawa for Academia Program” to Support Academic Research; Up to 10 Projects to Be Selected to Accelerate the Creation of Innovative Pharmaceuticals Originating in Japan

Highlights the Value of Human-Centered AI and the Competitive Advantage of “KIBIT” in Supporting Scientific Discovery

Aiming to develop drugs that meet unmet medical needs by advancing to animal testing in the future

Major update of the AI drug discovery support service Drug Discovery AI Factory and full-scale operation of the system that handles the upstream of the drug discovery value chain

Combining the AI drug discovery support service, Drug Discovery AI Factory, with the technological and research capabilities of academia to strengthen Japan's drug discovery capabilities through close collaboration between dry and wet research

Trial Utilizing Fukuoka Prefecture Subsidy Program Yields Positive Results